GWLL OTC
Goldenwell Biotech, Inc.
1W: +0.0%
1M: -1.5%
3M: +32.6%
YTD: -76.2%
1Y: +244.8%
$0.69
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$68.3M
52W Range0.2-10
Volume925
Avg Volume152
Beta4.60
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOShuang Liu
Employees3
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2022-09-30
Websitegoldenwellbiotech.com
7316 Capilano Dr.
Solon, OH 44139
US
Solon, OH 44139
US
440 666 7999
About Goldenwell Biotech, Inc.
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement. The company was incorporated in 2019 and is based in Hudson, Ohio.
Latest News
No recent news
Recent Insider Trades
No insider trades found